Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment

Although several therapeutics are used to treat coronavirus disease 2019 (COVID-19) patients, there is still no definitive metabolic marker to evaluate disease severity and recovery or a quantitative test to end quarantine. Because severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniell, Henry, Nair, Smruti K., Shi, Yao, Wang, Ping, Montone, Kathleen T., Shaw, Pamela A., Choi, Grace H., Ghani, Danyal, Weaver, JoEllen, Rader, Daniel J., Margulies, Kenneth B., Collman, Ronald G., Laudanski, Krzysztof, Bar, Katharine J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258412/
https://www.ncbi.nlm.nih.gov/pubmed/35818571
http://dx.doi.org/10.1016/j.omtm.2022.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258412/
https://www.ncbi.nlm.nih.gov/pubmed/35818571
http://dx.doi.org/10.1016/j.omtm.2022.07.003

Ejemplares similares